Q1 2024 Inovio Pharmaceuticals Inc Earnings Call Transcript
Good afternoon, ladies and gentlemen, and welcome to the Inovio first-quarter 2024 financial results conference call. (Operator Instructions) This call is being recorded on Monday, May 13, 2024.
I would now like to turn the conference over to Thomas Hong, Manager of Investor Relations. Please go ahead.
Good afternoon, and thank you for joining the Inovio first-quarter 2024 financial results conference call. Joining me on today's call are Dr. Jacqui Shea, President and Chief Executive Officer; Dr. Michael Sumner, Chief Medical Officer; Mark Twyman, Chief Commercial Officer; and Peter Kies, Chief Financial Officer.
Today's call will review our corporate and financial information for the quarter ended March 31, 2024, as well as provide a general business update. Following prepared remarks, we will conduct a question-and-answer segment. During the call, we will be making forward-looking statements regarding future events and the future performance of the company.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |